An investigation on behalf of current long term investors in Caribou Biosciences, Inc. (NASDAQ:CRBU) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
San Diego, CA -- (SBWIRE) -- 05/22/2023 -- Certain directors of Caribou Biosciences, Inc. are under investigation concerning potential breaches of fiduciary duties.
Investors who are current long term investors in Caribou Biosciences, Inc. (NASDAQ: CRBU) shares, have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: CRBU stocks follows a lawsuit filed against Caribou Biosciences, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CRBU stocks, concerns whether certain Caribou Biosciences, directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that the Offering Documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, the plaintiff alleges that between July 23, 2021 and December 9, 2022, the Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
More specifically, the plaintiff claims that the Offering Documents and the Defendants made false and/or misleading statements and/or failed to disclose thatCB-010's treatment effect was not as durable as Defendants had led investors to believe, that accordingly, CB-010's clinical and commercial prospects were overstated, and that as a result, the Offering Documents and Defendants' public statements between July 23, 2021 and December 9, 2022 were materially false and/or misleading and failed to state information required to be stated therein.
Those who purchased shares of Caribou Biosciences, Inc. (NASDAQ: CRBU) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.